CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Anticoagulants

Agents that prevent BLOOD CLOTTING.

Subtype terms (1)

More specific conditions that are subtypes of Anticoagulants in the MeSH hierarchy.

  • Antithrombins

    9 drugs (7 approved, 2 experimental)

Drugs by status

Phase 4 trials (24)

  • sodium citrate
  • edoxaban
  • heparin
  • human fibrin
  • procaine benzylpenicillin
  • dabigatran
  • calcium citrate
  • clavulanate
  • fluindione
  • warfarin
  • human factor ix complex (prothrombin complex concentrate)
  • acetylsalicylic acid
  • enoxaparin
  • phenprocoumon
  • inactivated influenza vaccine
  • rivaroxaban
  • bivalirudin
  • apixaban
  • tranexamic acid
  • clopidogrel
  • protamine sulfate
  • dalteparin
  • unfractionated heparin
  • tinzaparin

Phase 3 trials (4)

  • sintrom
  • argatroban
  • sulodexide
  • blood plasma

Phase 2 trials (3)

  • hydroxychloroquine
  • sodium phosphate
  • nafamostat

Phase 1 trials (4)

  • ciraparantag
  • duloxetine
  • sildenafil
  • ckd-344

Other trials (3)

  • vitamin k
  • vasopressin
  • nadroparin

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.